Market cap
₹5,378 Cr
Revenue (TTM)
₹2,527 Cr
P/E Ratio
16.2
P/B Ratio
2.4
Div. Yield
0.4 %
Quality Score
8/10
Growth Score
6/10
Valuation Score
7/10
Momentum Score
2/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹332 Cr
-
ROE
16.1 %
-
ROCE
15.7 %
-
Industry P/E
23.68
-
EV/EBITDA
10.2
-
Debt to Equity
0.3
-
Book Value
₹514.9
-
EPS
₹77
-
Face value
10
-
Shares outstanding
43,141,338
10 Years Aggregate
CFO
₹3,202.30 Cr
EBITDA
₹4,123.90 Cr
Net Profit
₹2,109.27 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Epigral
| 2.5 | 6.8 | 33.0 | -33.7 | 10.0 | -- | -- |
|
BSE Commodities
| 8.6 | 2.6 | 5.0 | 14.6 | 18.8 | 11.5 | 16.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Epigral
| -34.9 | 93.2 | -21.7 | 64.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Epigral
|
1,251.1 | 5,378.2 | 2,527.2 | 332.0 | 15.8 | 16.1 | 16.2 | 2.4 |
| 1,719.9 | 8,789.6 | 1,535.9 | 180.0 | 13.9 | 12.1 | 48.8 | 5.7 | |
| 3,489.6 | 15,096.5 | 15,226.8 | 420.1 | 3.4 | 10.7 | 35.9 | 3.8 | |
| 1,473.9 | 18,670.1 | 11,162.0 | 877.2 | 12.4 | 13.7 | 21.3 | 2.8 | |
| 1,821.8 | 6,454.9 | 5,248.3 | 267.4 | 6.7 | 10.5 | 24.1 | 2.4 | |
| 687.2 | 5,052.8 | 4,308.2 | 34.3 | 0.0 | -0.2 | -- | 0.9 | |
| 2,583.2 | 8,237.3 | 15,622.2 | 1,787.5 | 16.6 | 12.6 | 9.1 | 1.0 | |
| 5,135.7 | 6,982.5 | 1,886.6 | 168.0 | 11.4 | 16.6 | 41.6 | 5.2 | |
| 7,125.0 | 36,563.2 | 3,313.9 | 663.6 | 28.1 | 17.7 | 55.1 | 9.2 | |
| 750.2 | 19,100.4 | 14,584.0 | -1,882.0 | 4.1 | 0.6 | -- | 0.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Epigral
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda,... chlorine, hydrogen, and caustic potash products. It also engages in the trading of agrochemical products. It serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India. Read more
-
Incorporated
2007
-
Chairman
Maulik Patel
-
Managing Director
Maulik Patel
-
Group
Meghmani
-
Headquarters
Ahmedabad, Gujarat
-
Website
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsIntimation Of 19Th AGM To Be Held On 08.06.2026.
15-May-2026Corporate Action-Board approves Dividend
14-May-2026No News & Announcements are available.
FAQs for Epigral
What is the current share price of Epigral Ltd Today?
The share price of Epigral Ltd is ₹1,251.10 (NSE) and ₹1,246.65 (BSE) as of 22-May-2026 IST. Epigral Ltd has given a return of 10% in the last 3 years.
What is the current PB & PE ratio of Epigral Ltd?
The P/E ratio of Epigral Ltd is 16.20 times as on 22-May-2026, a 32 discount to its peers’ median range of 23.68 times.
The P/B ratio of Epigral Ltd is 2.42 times as on 22-May-2026, a 29 premium to its peers’ median range of 1.87 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
10.52
|
1.57
|
|
2025
|
22.90
|
4.30
|
|
2024
|
23.25
|
3.63
|
|
2023
|
11.09
|
3.67
|
|
2022
|
16.01
|
5.57
|
What is the 52 Week High and Low of Epigral Ltd?
The 52-week high and low of Epigral Ltd are Rs 2,114.00 and Rs 807.00 as of 22-May-2026.
What is the market cap of Epigral Ltd?
Epigral Ltd has a market capitalisation of ₹ 5,378 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Epigral Ltd?
Before investing in Epigral Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.